HARFORD MEMORIAL HOSPITAL
1. Target Overview & Investment Thesis
HARFORD MEMORIAL HOSPITAL is a 88-bed suburban community hospital in HARFORD, MD with $102.4M in net patient revenue and a -2.1% operating margin. The hospital serves a payer mix of 44.4% Medicare, 2.1% Medicaid, and 53.5% commercial.
Thesis: Turnaround. Our ML models identify $7.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -2.1% to 5.2% (+736bps).
| Net Revenue HCRIS | $102.4M |
| Current EBITDA COMPUTED | $-2.2M |
| Operating Margin COMPUTED | -2.1% |
| Occupancy HCRIS | 69.5% |
| Revenue / Bed COMPUTED | $1.2M |
| Net-to-Gross HCRIS | 86.5% |
| Distress Probability ML | 50.1% |
2. Market Context & Competitive Position
MD has 59 Medicare-certified hospitals with a median operating margin of -8.3%. The target's margin of -2.1% places it above the state median. Among 22 size-comparable peers (44-176 beds), the median margin is -3.7%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (44-176), prioritizing same-state peers. 22 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| HARFORD MEMORIAL HOSPITAL (Target) | MD | 88 | $102.4M | -2.1% |
| MERCY MEDICAL CENTER | MD | 173 | $561.3M | -3.3% |
| MEMORIAL EASTON | MD | 143 | $287.6M | -4.1% |
| CARROLL COUNTY GENERAL HOSPITA | MD | 165 | $226.9M | -3.3% |
| KENNEDY KRIEGER | MD | 50 | $203.5M | -50.0% |
| ST. MARYS HOSPITAL | MD | 105 | $198.5M | -1.5% |
| UNION HOSPITAL OF CECIL COUNTY | MD | 124 | $184.1M | -4.6% |
| MEDSTAR HARBOR HOSPITAL | MD | 142 | $178.3M | -13.3% |
| MEDSTAR MONTGOMERY MEDICAL CEN | MD | 96 | $173.7M | -14.1% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $7.5M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $2.2M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $2.0M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $2.0M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.2M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $66K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-2.2M |
| + RCM Uplift | +$7.5M |
| Pro Forma EBITDA | $5.4M |
| Current Margin | -2.1% |
| Pro Forma Margin | 5.2% |
| WC Released (1x) | $3.9M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-3.3M | $61.1M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-3.3M | $66.1M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-3.0M | $89.9M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-3.0M | $97.2M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-3.7M | $24.5M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-3.7M | $25.8M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| High | Elevated distress probability | Model estimates 50.1% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 22 hospitals with 44-176 beds
- Same-state prioritization (n=23)
- Comp margins: P25=-13.0% / P50=-3.7% / P75=0.2%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.